“I have a background as a scientist although I am serving a different role now as the CEO. I feel very proud to have shown a good case of solid science leading to business,” stated Sang Hoon Lee, CEO and founder of ABL Bio Inc., which reached a major global out-licensing deal with Sanofi in January.
The potential $1
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?